omega-n-methylarginine has been researched along with tamoxifen in 5 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (tamoxifen) | Trials (tamoxifen) | Recent Studies (post-2010) (tamoxifen) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 20,630 | 2,227 | 6,256 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arriero, MD; Casado, S; de Frutos, T; Díaz-Recasens, J; Farré, J; García, R; García-Durán, M; García-Gálvez, G; González-Fernández, F; Jiménez, A; López-Farré, A; Montón, M; Rico, L; Sánchez de Miguel, L | 1 |
| Davidge, ST; Stewart, KG; Zhang, Y | 1 |
| Batten, JJ; Kakkar, AK; Mathie, RT; Sirivatanauksorn, Y; Thamrongwittawatpong, L; Williamson, RC | 1 |
| Peer, NG; Ruers, TJ; te Boekhorst, DS; van der Sluis, RF; Wobbes, T | 1 |
| Broemeling, LD; Ekmekcioglu, S; Grimm, EA; Simeone, AM; Tari, AM | 1 |
5 other study(ies) available for omega-n-methylarginine and tamoxifen
| Article | Year |
|---|---|
Estrogen stimulates neuronal nitric oxide synthase protein expression in human neutrophils.
Topics: Adult; Aged; Cardiovascular Diseases; CD18 Antigens; Cell Adhesion; Enzyme Induction; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Hormone Replacement Therapy; Humans; Luteinizing Hormone; Male; Menstrual Cycle; Middle Aged; Neutrophils; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; omega-N-Methylarginine; Postmenopause; Premenopause; Receptors, Estrogen; Sex Characteristics; Tamoxifen | 1999 |
Endogenous estrogen mediates vascular reactivity and distensibility in pregnant rat mesenteric arteries.
Topics: Adaptation, Physiological; Animals; Blotting, Western; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Estrogen Antagonists; Estrogens; Female; Mesenteric Arteries; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroprusside; omega-N-Methylarginine; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Tamoxifen; Vasodilation; Vasodilator Agents | 2001 |
The effect of N(G)-monomethyl-L-arginine and tamoxifen on nitric oxide production in breast cancer cells stimulated by oestrogen and progesterone.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Enzyme Inhibitors; Estrogens; Female; Humans; Neovascularization, Pathologic; Nitric Oxide; omega-N-Methylarginine; Progesterone; Tamoxifen; Tumor Cells, Cultured | 2001 |
Periodic follow-up after breast cancer and the effect on survival.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Continuity of Patient Care; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Netherlands; Nitric Oxide; omega-N-Methylarginine; Retrospective Studies; Survival Analysis; Tamoxifen | 2001 |
A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxide.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Division; Enzyme Inhibitors; Fenretinide; Flow Cytometry; Humans; Immunohistochemistry; Interferon-gamma; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Tamoxifen; Tumor Cells, Cultured | 2002 |